NCT04339322

Brief Summary

The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2020

Completed
22 days until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

3 months

First QC Date

April 7, 2020

Last Update Submit

April 7, 2020

Conditions

Characteristics DiseasesOutcome, Fatal

Keywords

Covid-19characteristicsOutcomeEgypt

Outcome Measures

Primary Outcomes (4)

  • Demographics of Coronavirus Disease 2019 (COVID-19) in the cohort group

    Sheet recording age, sex, co-morbidity,history of contact

    2 months

  • Clinical manifestations of Coronavirus Disease 2019 (COVID-19)

    Sheet recording symptoms and signs

    2 month

  • Laboratory data of included Coronavirus Disease 2019 (COVID-19) cohort

    blood picture,D-Dimer, creatinine, liver enzymes

    2 months

  • Radiological features of Coronavirus Disease 2019 (COVID-19) cohort

    Chest x-ray and/or Computed tomography

    2 month

Secondary Outcomes (1)

  • outcomes of Coronavirus Disease 2019 (COVID-19) infection in the cohort group

    1 week

Study Arms (1)

Patients with Covid-19

Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health

Other: Follow up

Interventions

Follow upOTHER

Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.

Patients with Covid-19

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health.

You may qualify if:

  • Patients with diagnosis of Covid-19 .

You may not qualify if:

  • Patients refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Tropical Medicine and Gastroenterology

Study Record Dates

First Submitted

April 7, 2020

First Posted

April 9, 2020

Study Start

May 1, 2020

Primary Completion

July 30, 2020

Study Completion

July 30, 2020

Last Updated

April 9, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

The data prescribed in the study